These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 22155366)
41. Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model. Wang X; Constans MM; Chebib FT; Torres VE; Pellegrini L Am J Nephrol; 2019; 49(6):487-493. PubMed ID: 31117065 [TBL] [Abstract][Full Text] [Related]
45. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis. Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245 [TBL] [Abstract][Full Text] [Related]
46. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin. Kim I; Ding T; Fu Y; Li C; Cui L; Li A; Lian P; Liang D; Wang DW; Guo C; Ma J; Zhao P; Coffey RJ; Zhan Q; Wu G J Am Soc Nephrol; 2009 Dec; 20(12):2556-69. PubMed ID: 19939939 [TBL] [Abstract][Full Text] [Related]
47. Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease. Wang X; Jiang L; Thao K; Sussman CR; LaBranche T; Palmer M; Harris PC; McKnight GS; Hoeflich KP; Schalm S; Torres VE J Am Soc Nephrol; 2022 Jun; 33(6):1087-1104. PubMed ID: 35236775 [TBL] [Abstract][Full Text] [Related]
48. Role of genetic modifiers in an orthologous rat model of ARPKD. O'Meara CC; Hoffman M; Sweeney WE; Tsaih SW; Xiao B; Jacob HJ; Avner ED; Moreno C Physiol Genomics; 2012 Aug; 44(15):741-53. PubMed ID: 22669842 [TBL] [Abstract][Full Text] [Related]
49. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065 [TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2 Monirujjaman M; Aukema HM J Nephrol; 2019 Jun; 32(3):401-409. PubMed ID: 30671914 [TBL] [Abstract][Full Text] [Related]
51. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease. Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of Mast Cell Degranulation With Cromolyn Sodium Exhibits Organ-Specific Effects in Polycystic Kidney (PCK) Rats. Jiang L; Fang P; Septer S; Apte U; Pritchard MT Int J Toxicol; 2018; 37(4):308-326. PubMed ID: 29862868 [TBL] [Abstract][Full Text] [Related]
53. A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Fedeles SV; Tian X; Gallagher AR; Mitobe M; Nishio S; Lee SH; Cai Y; Geng L; Crews CM; Somlo S Nat Genet; 2011 Jun; 43(7):639-47. PubMed ID: 21685914 [TBL] [Abstract][Full Text] [Related]
54. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis. Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683 [TBL] [Abstract][Full Text] [Related]
55. Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice. Smithline ZB; Nikonova AS; Hensley HH; Cai KQ; Egleston BL; Proia DA; Seeger-Nukpezah T; Golemis EA PLoS One; 2014; 9(12):e114403. PubMed ID: 25474361 [TBL] [Abstract][Full Text] [Related]
56. Adult Inactivation of the Recessive Polycystic Kidney Disease Gene Causes Polycystic Liver Disease. Besse W; Roosendaal C; Tuccillo L; Roy SG; Gallagher AR; Somlo S Kidney360; 2020 Oct; 1(10):1068-1076. PubMed ID: 33554127 [TBL] [Abstract][Full Text] [Related]
58. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310 [TBL] [Abstract][Full Text] [Related]
59. IFT-A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease. Wang W; Pottorf TS; Wang HH; Dong R; Kavanaugh MA; Cornelius JT; Dennis KL; Apte U; Pritchard MT; Sharma M; Tran PV J Pathol; 2021 Jul; 254(3):289-302. PubMed ID: 33900625 [TBL] [Abstract][Full Text] [Related]
60. Blockade of Hedgehog Signaling Attenuates Biliary Cystogenesis in the Polycystic Kidney (PCK) Rat. Sato Y; Yamamura M; Sasaki M; Harada K Am J Pathol; 2018 Oct; 188(10):2251-2263. PubMed ID: 30036521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]